Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?
Open Access
- 28 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (17) , 1790-1796
- https://doi.org/10.1093/eurheartj/ehi290
Abstract
Aims In aortic stenosis (AS), left ventricular (LV) hypertrophy is considered a compensatory response helping maintain systolic function. Recent research in experimental AS suggests, however, that LV hypertrophy is not necessary to sustain LV contractions but may in fact be maladaptive. The present work aimed to clarify the role of LV hypertrophy in AS-related heart failure (HF) in man. Methods and results We studied 137 adult patients with isolated AS undergoing pre-operative echocardiography and cardiac catheterization. HF was diagnosed by the European criteria and LV hypertrophy by sex-specific limits of echocardiographic LV mass. The higher the LV mass was, the poorer was the LV ejection fraction (β=−0.26, PP2/m2, n=85), patients with absent LV hypertrophy (n=19) had better preserved ejection fraction (mean±SE, 64±3 vs. 57±2%, P=0.045) and less HF (16 vs. 48%, P=0.025) than patients with LV hypertrophy (n=66). Conclusion In isolated AS, increased LV mass predicts the presence of systolic dysfunction and HF independent of the severity of valvular obstruction. LV hypertrophy may be maladaptive rather than beneficial in AS in man.Keywords
This publication has 39 references indexed in Scilit:
- Diagnosing heart failure in aortic valve stenosisJournal of Internal Medicine, 2004
- Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction–pilot study of enalapril in aortic stenosis (SCOPE-AS)American Heart Journal, 2004
- Hypertrophy of the HeartCirculation, 2004
- Targeted Inhibition of Calcineurin in Pressure-overload Cardiac HypertrophyPublished by Elsevier ,2002
- Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivoProceedings of the National Academy of Sciences, 2002
- Chronic N G -Nitro- l -Arginine Methyl Ester–Induced HypertensionCirculation, 2000
- Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 1998
- Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sampleJournal of the American College of Cardiology, 1993
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Wall stress and patterns of hypertrophy in the human left ventricle.Journal of Clinical Investigation, 1975